股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 FF301 致：香港交易及結算所有限公司 公司名稱: 美亞娛樂資訊集團有限公司 （於百慕達註冊成立之有限公司） 截至月份: 2026年2月28日 狀態: 新提交 呈交日期: 2026年3月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00391 | 說明 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | 15,000,000,000 | HKD | | 0.02 HKD | | 300,000,000 | | 增加 / 減少 (-) | | | 0 | | HKD | | 0 | | 本月底結存 | | 15,000,000,000 | HKD | | 0.02 HKD | | 300,000,000 | 本月底法定/註冊股本總額： ...

Group 1 - The core point of the news is that *ST Changyao has faced significant legal and regulatory challenges, including multiple lawsuits and allegations of financial misconduct, which may lead to the termination of its stock listing [2][3] Group 2 - On February 24, 2026, *ST Changyao and its subsidiary Hebei Yihang Technology Co., Ltd. were involved in 7 new lawsuits, with a total amount of 17.88 million yuan. Over the past 12 months, the total amount involved in lawsuits and arbitration has reached approximately 54.6952 million yuan, accounting for 12.64% of the latest audited net assets [1] - On January 23, 2026, *ST Changyao received an administrative penalty decision from the China Securities Regulatory Commission, which found that the company had falsely recorded financial data in its annual reports for 2021, 2022, and 2023. The total inflated revenue amounted to 733 million yuan, with inflated total profits of 163 million yuan [2] - Following the administrative penalty, *ST Changyao's stock is set to be suspended from trading starting January 26, 2026, due to potential termination of its listing by the Shenzhen Stock Exchange [2]

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 FF301 II. 已發行股份及/或庫存股份變動及足夠公眾持股量的確認 致：香港交易及結算所有限公司 公司名稱: 美亞娛樂資訊集團有限公司 （於百慕達註冊成立之有限公司） 呈交日期: 2026年2月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00391 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 15,000,000,000 | HKD | | 0.02 | HKD | | 300,000,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | 0 | | 本月底結存 | ...

Core Viewpoint - *ST Changyao has been penalized for financial fraud, facing a fine of 10 million yuan and a proposed termination of its stock listing due to serious violations over three consecutive years [2][5][7]. Group 1: Financial Penalties and Violations - The company was fined 10 million yuan for financial fraud, as confirmed by the China Securities Regulatory Commission (CSRC) [2][5]. - The CSRC has indicated that it will transfer any criminal evidence related to the case to the public security authorities for further investigation [2]. - The company has been found to have inflated revenue and profit figures in its annual reports from 2021 to 2023, with inflated revenues of 215 million yuan, 284 million yuan, and 234 million yuan, representing 9.12%, 17.57%, and 19.51% of reported revenues respectively [5]. Group 2: Stock Listing Status - The Shenzhen Stock Exchange has issued a notice proposing to terminate the company's stock listing, with trading suspension set to begin on January 26, 2026 [6][7]. - The company has already triggered conditions for mandatory delisting due to significant legal violations [9]. - The stock has experienced a significant price increase, with a cumulative rise of 107.75% over four trading days leading up to January 23, 2026 [9].

Core Viewpoint - *ST Changyao has been penalized for financial fraud, facing a fine of 10 million yuan and a proposed termination of its stock listing due to serious violations over three consecutive years [1][2]. Group 1: Financial Fraud Details - The company was found to have inflated revenue by 215 million yuan, 284 million yuan, and 234 million yuan for the years 2021, 2022, and 2023 respectively, which accounted for 9.12%, 17.57%, and 19.51% of the reported revenue for those years [4]. - The inflated total profit for the same years was 56.4 million yuan, 63.4 million yuan, and 43.7 million yuan, representing 35.62%, 88.23%, and 6.42% of the reported profit [4]. - An additional profit inflation of 4.55 million yuan was noted for 2022 due to improper loss recognition related to a project, which constituted 6.34% of the reported profit for that year [5]. Group 2: Regulatory Actions - The China Securities Regulatory Commission (CSRC) issued an administrative penalty decision on January 23, confirming the company's violations and imposing a fine [2][5]. - The company is subject to potential criminal prosecution as the CSRC has indicated it will refer any criminal evidence to the public security authorities [1]. - According to the Shenzhen Stock Exchange rules, the company has triggered conditions for mandatory delisting due to significant legal violations [8]. Group 3: Market Reaction - *ST Changyao's stock experienced a significant increase, with a cumulative price increase of 41.44% over two trading days and 107.75% over four trading days leading up to January 23 [8]. - As of January 23, the stock closed at 0.92 yuan per share, with a total market capitalization of 322 million yuan [8].

Group 1 - *ST Changyao has been found to have committed violations related to financial reporting, including the acquisition of 52.75% of Hubei Changjiang Star Pharmaceutical Co., Ltd. in November 2020, which was subsequently consolidated into its financial statements [2] - From 2021 to 2023, subsidiaries of Changjiang Star fabricated inventory and sales documents, leading to inflated revenues of 215.32 million, 283.74 million, and 233.63 million yuan for the respective years, representing 9.12%, 17.57%, and 19.51% of reported revenues [3] - The inflated total profits for the same years were 56.40 million, 63.38 million, and 43.71 million yuan, accounting for 35.62%, 88.23%, and 6.42% of the reported total profits [3] Group 2 - The company has been warned that its financial reporting from 2021 to 2023 contains false records, which may lead to the termination of its stock listing under the revised rules of the Growth Enterprise Market [3] - As of January 23, *ST Changyao's stock has experienced a continuous rise, with a total increase of 109.09%, reaching a price of 0.92 yuan per share and a market capitalization of 322 million yuan [4] Group 3 - The current regulatory environment is increasingly focused on combating financial fraud, with multiple departments collaborating to strengthen oversight and enforcement against such practices [6] - A recent meeting highlighted a shift in regulatory strategy from reactive punishment to proactive prevention and comprehensive accountability across all parties involved, including major shareholders and intermediaries [6] - The establishment of a comprehensive prevention and punishment system aims to enhance the integrity of the capital market, ensuring that fraudulent activities are met with severe consequences and that investors have avenues for compensation [6]

Group 1 - The core issue is that *ST Changyao has been penalized by the China Securities Regulatory Commission (CSRC) for financial misconduct, including false reporting of revenues and profits from 2021 to 2023, leading to a fine of 10 million yuan [2] - The company inflated its operating income by 215 million yuan, 284 million yuan, and 234 million yuan for the years 2021, 2022, and 2023, respectively, which accounted for 9.12%, 17.57%, and 19.51% of the reported operating income for those years [2] - The inflated total profit amounted to 56.4 million yuan, 63.4 million yuan, and 43.7 million yuan for the same years, representing 35.62%, 88.23%, and 6.42% of the reported total profit [2] Group 2 - The Hubei Securities Regulatory Bureau stated that *ST Changyao's continuous financial fraud is severe and has significantly harmed investors' interests, disrupting the normal order of the capital market [2] - The CSRC demonstrated a strong stance against market irregularities by processing the case from initiation to penalty decision in just over two months, reflecting a "zero tolerance" policy [2] - On January 23, *ST Changyao announced it received a notice from the Shenzhen Stock Exchange regarding the potential termination of its stock listing, with trading suspension set to begin on January 26 [4] Group 3 - As of January 23, *ST Changyao's stock closed at 0.92 yuan per share, with a total market capitalization of 322 million yuan [7] - The stock experienced a speculative surge, with a cumulative price deviation of 41.44% and a total deviation of 107.75% over four consecutive trading days [5] - The Hubei Securities Regulatory Bureau warned that the recent price movements are typical speculative trading, ignoring the reality of the company's impending administrative penalties and potential delisting due to serious violations [7]

1月23日晚，*ST长药（300391）发布公告，公司于1月23日收到深交所下发的《事先告知书》，拟决定 终止公司股票上市交易。公司股票自1月26日开市起停牌。 湖北证监局表示，*ST长药连续多年财务造假，性质恶劣，严重损害广大投资者利益，扰乱了资本市场 正常秩序。证监会在*ST长药财务造假案件查处过程中，从立案到下发行政处罚决定书仅用时两个多 月，充分彰显了监管机构对资本市场乱象"零容忍"的坚决态度以及保护投资者合法权益的坚定决心。 值得注意的是，今天A股出现了"小强大弱"的普涨行情，濒临退市的*ST长药、*ST立方等连续4天盘中触 及20%涨停。*ST长药今晚发布的股价异动公告显示，公司股票于1月22日、1月23日连续2个交易日内日 收盘价格涨幅偏离值累计41.44%，于1月20日至1月23日连续4个交易日内日收盘价格涨幅偏离值累计 107.75%。 湖北证监局表示，近期市场对"*ST"相关概念进行投机性炒作，*ST长药、*ST立方等面临重大违法退市 风险的股票连续涨停。当前的股价异动，无视上市公司面临行政处罚、将因重大违法强制退市的现实， 是典型的投机炒作，积聚了巨大的投资风险，广大投资者应坚守理性投资 ...

面临重大违法强制退市、交易类强制退市、财务类强制退市等三重退市风险的*ST长药（300391），迎 来了毫无意外的结局。 1月23日晚间，*ST长药发布公告称，公司当日收到证监会下发的《行政处罚决定书》。经证监会查 明，*ST长药2021年至2023年年度报告存在虚假记载。证监会决定对*ST长药责令改正，给予警告，并 处以1000万元罚款。同时，因*ST长药触及重大违法强制退市情形，公司股票将于2026年1月26日起停 牌，深圳证券交易所将依规启动退市程序。 退市风险重重，仍被炒至"四连板" 此前，*ST长药因涉嫌定期报告等财务数据虚假记载，被中国证监会立案调查，公司及相关人员于2025 年12月26日收到中国证监会下发的《行政处罚事先告知书》。公司2021年、2022年、2023年年度报告存 在虚假记载，可能触及重大违法强制退市情形，公司股票可能被实施重大违法强制退市。公司股票交易 于2025年12月29日起被叠加实施退市风险警示。 有接受采访的券商人士表示，*ST长药连续多年财务造假，性质恶劣，严重损害广大投资者利益，扰乱 了资本市场正常秩序。证监会在*ST长药财务造假案件查处过程中，从立案到下发行政处罚 ...

Core Viewpoint - *ST Changyao (300391.SZ) has been identified by the China Securities Regulatory Commission (CSRC) for false disclosures in its annual reports for 2021, 2022, and 2023, which may lead to the termination of its stock listing due to significant violations of the Shenzhen Stock Exchange's listing rules [1][2] Group 1 - The company received a decision from the CSRC stating that its annual reports contained false records, affecting key financial indicators such as revenue, total profit, and net profit [1] - The company has triggered a major violation that could lead to forced delisting, as it has false disclosures for three consecutive years [1] - According to the Shenzhen Stock Exchange's rules, if a company encounters more than two delisting conditions, its stock will be delisted based on the principle of "first come, first served" [1] Group 2 - The company's stock will be suspended from trading starting January 26, 2026, as per the relevant regulations [2] - The company has the right to apply for a hearing regarding the delisting notice, and if it fails to do so within the specified period, the Shenzhen Stock Exchange will make an independent judgment on the delisting matter [2] - If a hearing application is submitted, the Shenzhen Stock Exchange will form an opinion within fifteen trading days after the hearing process concludes [2]